These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20393303)

  • 1. Gene patents and licensing: case studies prepared for the Secretary's Advisory Committee on Genetics, Health, and Society.
    Cook-Deegan R; Heaney C
    Genet Med; 2010 Apr; 12(4 Suppl):S1-2. PubMed ID: 20393303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
    Colaianni A; Chandrasekharan S; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.
    Cook-Deegan R; DeRienzo C; Carbone J; Chandrasekharan S; Heaney C; Conover C
    Genet Med; 2010 Apr; 12(4 Suppl):S15-38. PubMed ID: 20393305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
    Chandrasekharan S; Heaney C; James T; Conover C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S194-211. PubMed ID: 20393308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myriad Genetics: In the eye of the policy storm.
    Gold ER; Carbone J
    Genet Med; 2010 Apr; 12(4 Suppl):S39-70. PubMed ID: 20393310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.
    Chandrasekharan S; Pitlick E; Heaney C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S155-70. PubMed ID: 20393306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis: Secretary's Advisory Committee on Genetics, Health, and Society Report falls short.
    Klein RD
    Hum Pathol; 2009 Feb; 40(2):147-55. PubMed ID: 19084265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of gene patents and licensing practices on access to genetic testing for hearing loss.
    Chandrasekharan S; Fiffer M
    Genet Med; 2010 Apr; 12(4 Suppl):S171-93. PubMed ID: 20393307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patenting and licensing in genetic testing.
    ESHG Working Party on Patenting and Licensing
    Eur J Hum Genet; 2008 Apr; 16(4):405-11. PubMed ID: 18354424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome.
    Angrist M; Chandrasekharan S; Heaney C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S111-54. PubMed ID: 20393304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene patenting and licensing: the role of academic researchers and advocacy groups.
    Ledbetter DH
    Genet Med; 2008 May; 10(5):314-9. PubMed ID: 18496028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia.
    Berthels N; Matthijs G; Van Overwalle G
    Eur J Hum Genet; 2011 Nov; 19(11):1114-21. PubMed ID: 21811306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretary's advisory committee on genetic testing: its emerging role in public policy deliberation on genetic tests.
    Carr S; Goodwin SM
    Natl Forum; 1999; 79(3):26-30. PubMed ID: 12455552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-sequence patenting: National Society of Genetic Counselors (NSGC) position paper.
    McIntosh N; Braddock BR; Branda KJ; Eanet K; Goldberg S; Kieffer SA; Primiano L; Quercia N; Taylor KA; Tsipis J; Yashar BM; Yesley A;
    J Genet Couns; 2002 Aug; 11(4):241-3. PubMed ID: 12735296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. University opposition to unfettered research: a new bedfellow for biotech?
    Record KL
    Health Matrix Clevel; 2012; 22(1):139-67. PubMed ID: 22616545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on the impact of gene patents and licensing practices on access to genetic testing: lessons from hereditary hemorrhagic telangiectasia.
    Messner DA; Pyeritz RE; Bernhardt BA
    Genet Med; 2010 Nov; 12(11):746-8. PubMed ID: 21068576
    [No Abstract]   [Full Text] [Related]  

  • 18. Spinocerebellar ataxia: patient and health professional perspectives on whether and how patents affect access to clinical genetic testing.
    Powell A; Chandrasekharan S; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S83-S110. PubMed ID: 20393313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretary's Advisory Committee on Heritable Disorders in Newborns and Children response to the President's Council on Bioethics report: the changing moral focus of newborn screening.
    Trotter TL; Fleischman AR; Howell RR; Lloyd-Puryear M;
    Genet Med; 2011 Apr; 13(4):301-4. PubMed ID: 21407080
    [No Abstract]   [Full Text] [Related]  

  • 20. The fate and future of patents on human genes and genetic diagnostic methods.
    Huys I; Matthijs G; Van Overwalle G
    Nat Rev Genet; 2012 May; 13(6):441-8. PubMed ID: 22596320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.